Advertisement

Reactions Weekly

, Volume 1159, Issue 1, pp 2–2 | Cite as

FDA investigates death after colistimethate inhalation

News item
  • 10 Downloads

Keywords

Cystic Fibrosis Respiratory Distress Respiratory Failure Acute Respiratory Distress Syndrome Cystic Fibrosis Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

REFERENCE

  1. 1.
    FDA.Information for healthcare professionals: colistimethate (marketed as Coly-Mycin M and generic products). Internet Document: [3 pages], 28 Jun 2007. Available from: URL: http://www.fda.gov

Copyright information

© Adis International limited or Adis Data Information BV 2007

Personalised recommendations